Sinsin Pharmaceutical Co., Ltd (KOSDAQ: 002800)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,370.00
-90.00 (-1.65%)
Dec 20, 2024, 9:00 AM KST

Sinsin Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
81,46694,66484,65197,850138,658103,463
Upgrade
Market Cap Growth
3.35%11.83%-13.49%-29.43%34.02%-6.96%
Upgrade
Enterprise Value
121,451135,899130,024145,574183,301156,596
Upgrade
Last Close Price
5370.006240.005524.576328.088967.246691.09
Upgrade
PE Ratio
20.4620.2319.18-382.3448.40
Upgrade
PS Ratio
0.770.920.921.322.071.52
Upgrade
PB Ratio
1.241.521.421.792.471.84
Upgrade
P/TBV Ratio
1.511.531.431.802.491.85
Upgrade
P/FCF Ratio
23.70-18.59---
Upgrade
P/OCF Ratio
14.2424.0915.504220.6674.34-
Upgrade
EV/Sales Ratio
1.151.321.411.972.732.31
Upgrade
EV/EBITDA Ratio
11.6213.6714.1662.51-44.74
Upgrade
EV/EBIT Ratio
19.4722.6423.96--67.24
Upgrade
EV/FCF Ratio
35.33-28.56---
Upgrade
Debt / Equity Ratio
0.660.720.730.840.810.96
Upgrade
Debt / EBITDA Ratio
4.154.484.7319.85-15.39
Upgrade
Debt / FCF Ratio
12.61-9.55---
Upgrade
Asset Turnover
0.830.840.780.640.540.57
Upgrade
Inventory Turnover
4.754.604.984.603.843.95
Upgrade
Quick Ratio
0.650.590.710.760.770.78
Upgrade
Current Ratio
0.940.911.061.081.151.28
Upgrade
Return on Equity (ROE)
6.04%7.64%7.62%-2.62%0.36%3.65%
Upgrade
Return on Assets (ROA)
3.04%3.06%2.88%-0.72%-2.11%1.23%
Upgrade
Return on Capital (ROIC)
3.64%3.58%3.32%-0.83%-2.46%1.50%
Upgrade
Earnings Yield
4.89%4.94%5.21%-1.51%0.26%2.07%
Upgrade
FCF Yield
4.22%-1.14%5.38%-2.72%-7.29%-24.17%
Upgrade
Dividend Yield
1.12%0.96%---0.42%
Upgrade
Payout Ratio
22.85%16.21%--117.13%23.42%
Upgrade
Total Shareholder Return
1.12%0.96%---0.42%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.